Iopromide

• Description:

  Iopromide is a non-ionic, monomeric, iodine-based contrast medium for intravascular administration.

• UNSPSC:

  12352005

• Hazard Statement:

  H410

• Target:

  Biochemical Assay Reagents

• Type:

  Reference compound

• Related Pathways:

  Others

• Applications:

  COVID-19-immunoregulation

• Field of Research:

  Cardiovascular Disease

• Assay Protocol:

  https://www.medchemexpress.com/Iopromide.html

• Purity:

  99.03

• Solubility:

  DMSO : 100 mg/mL (ultrasonic) |H2O : 100 mg/mL (ultrasonic)

• Smiles:

  O=C (C1=C (I) C (NC (COC) =O) =C (I) C (C (NCC (O) CO) =O) =C1I) N (CC (O) CO) C

• Molecular Formula:

  C18H24I3N3O8

• Molecular Weight:

  791.11

• Precautions:

  H410

• References & Citations:

  [1]Jiang W, et al. Breviscapine attenuatted contrast medium-induced nephropathy via PKC/Akt/MAPK signalling in diabetic mice. Am J Transl Res. 2016 Feb 15;8 (2) :329-41.|[2]McCormack PL, et al. Iobitridol: a review of its use as a contrast medium in diagnostic imaging. Clin Drug Investig. 2013 Feb;33 (2) :155-66.

• Shipping Conditions:

  Room Temperature

• Storage Conditions:

  -20°C, 3 years; 4°C, 2 years (Powder)

• Scientific Category:

  Reference compound1

• Clinical Information:

  Launched

• CAS Number:

  73334-07-3